Search results for " Viral Protein U Antibody"

< >

V5-TAG, Monoclonal Antibody (Cat# AAA212109)

Full Name

MOUSE ANTI V5-TAG

Applications

EIA, FC/FACS, IF, IP, WB, RIA

Pricing

$785/1 mg | $3,370/5x1 mg

< >

V5-TAG, Monoclonal Antibody (Cat# AAA210328)

Full Name

MOUSE ANTI V5-TAG:Biotin

Applications

EIA, WB

Pricing

$445/0.1 mg | $1,845/5x0.1 mg

< >

V5-TAG, Monoclonal Antibody (Cat# AAA214958)

Full Name

MOUSE ANTI V5-TAG:HRP

Applications

EIA, WB

Pricing

$490/0.1 mg | $2,060/5x0.1 mg

< >

V5-TAG, Monoclonal Antibody (Cat# AAA210664)

Full Name

MOUSE ANTI V5-TAG:FITC

Applications

IF

Pricing

$445/0.1 mg | $1,845/5x0.1 mg

< >

V5-TAG, Monoclonal Antibody (Cat# AAA216888)

Full Name

MOUSE ANTI V5-TAG

Applications

EIA, FC/FACS, IF, IP, WB, RIA

Pricing

$1,350/2 mg | $5,915/5x2 mg

gp120 (HIV-1/Clade B), Recombinant Protein (Cat# AAA434004)

Full Name

gp120 (HIV-1/Clade B) (amino acid 24-518)

Applications

WB, EIA

Purity

> 95% purity (SDS-PAGE)

Pricing

$425/0.05 mg | $1,760/5x0.05 mg

E (DIII) (WNV), Recombinant Protein (Cat# AAA434001)

Full Name

West Nile Virus E (DIII) Protein

Applications

Western Blot standard, antibody ELISA, antigen, etc

Purity

> 95% purity (SDS-PAGE)

Pricing

$410/0.05 mg | $1,700/5x0.05 mg

Spike(Beijing02)(SARS-CoV), Recombinant Protein (Cat# AAA434077)

Full Name

Spike (aa 1-1190)(Beijing02)(SARS-CoV)

Applications

Western Blot Standard, Antibody ELISA, Antigen, Etc.

Pricing

$450/0.05 mg | $1,880/5x0.05 mg

< >

HIV-1 gp140, Recombinant Protein (Cat# AAA434072)

Full Name

HIV-1 gp140 (Clade C) protein (amino acid 24-680), trimer majority

Applications

Western blot standard, antibody ELISA, HIV-1 entry inhibition, etc.

Pricing

$410/0.05 mg | $1,700/5x0.05 mg

gp120 (MN) (HIV-1/Clade B), Recombinant Protein (Cat# AAA434051)

Full Name

gp120 (MN) (HIV-1/Clade B) (aa 30-513)

Applications

Western Blot standard, antibody ELISA, HIV-1 entry inhibition

Purity

> 95% purity (SDS-PAGE)

Pricing

$410/0.05 mg | $1,700/5x0.05 mg

Viral Protein U, Polyclonal Antibody (Cat# AAA540387)

Full Name

Viral Protein U Antibody

Reactivity

Human Immunodeficiency Virus 1

Applications

CM, EIA, ICC, IF, IHC, IP, WB

Pricing

$490/0.1 mg | $2,065/5x0.1 mg

< >

Membrane Glycoprotein G1 of Phlebovirus, Recombinant Protein (Cat# AAA434236)

Full Name

Membrane Glycoprotein G1 of Phlebovirus (SFTS virus HN6)

Applications

Western blot standard, antibody ELISA, antigen, etc.

Purity

> 80% purity by SDS-PAGE gel

Pricing

$385/0.05 mg | $1,580/5x0.05 mg

Measles Virus, Monoclonal Antibody (Cat# AAA319675)

Full Name

Measles Virus

Applications

EIA, IFA

Purity

> 90 % Pure. Protein A Chromatography

Pricing

$920/1 mg | $3,995/5x1 mg

< >

<< Previous Next >>

Western Blot (WB) (Western Blot analysis in MCF7 cell line lysates (35ug/lane) using MBS625868. BMI1 (arrow) was detected using MBS625868.)

BMI1, Polyclonal Antibody (Cat# AAA625868)

Full Name

BMI1 (Polycomb Complex Protein BMI-1, Polycomb Group RING Finger Protein 4, RING Finger Protein 51, BMI1, PCGF4, RNF51)

Gene Names

BMI1; PCGF4; RNF51; FLVI2/BMI1

Reactivity

Human

Applications

EL/EIA, WB

Purity

Affinity Purified
Purified by immunoaffinity chromatography.

Pricing

$675/0.2 mL | $3,020/5x0.2 mL

Viral Protein U, Polyclonal Antibody (Cat# AAA5400233)

Full Name

Viral Protein U Antibody FITC-Conjugated

Reactivity

Human Immunodeficiency Virus 1

Applications

CM, EIA, ICC, IF, IHC, IP, WB

Purity

Antigen Affinity Purified

Pricing

$560/0.1 mg | $2,380/5x0.1 mg

Viral Protein U, Polyclonal Antibody (Cat# AAA5400232)

Full Name

Viral Protein U Antibody BIOTIN

Reactivity

Human Immunodeficiency Virus 1

Applications

CM, EIA, ICC, IF, IHC, IP, WB

Pricing

$560/0.1 mg | $2,380/5x0.1 mg

XBP1, Polyclonal Antibody (Cat# AAA1491360)

Full Name

Rabbit Anti Human XBP1 PolyClonal Antibody

Gene Names

XBP1; XBP2; TREB5; XBP-1

Reactivity

Human, Mouse, Rat

Applications

WB, IHC

Purity

Affinity Purification

Pricing

$320/0.1 mL | $1,440/5x0.1 mL

HA (B/Colorado/06/2017), Recombinant Protein (Cat# AAA430291)

Full Name

HA (aa 16-546)(B/Colorado/06/2017)

Applications

Western blot standard, antibody ELISA, antigen, etc.

Purity

> 95% purity (SDS PAGE)

Pricing

$355/0.05 mg | $1,440/5x0.05 mg

Viral Protein U, Positive Control (Cat# AAA543376)

Full Name

Viral Protein U Antibody Western Blot Positive Control

Applications

WB

Pricing

$335/5 Applications | $1,350/5x5 Applications

COVID 19 Spike RBD Brazil Variant Coronavirus, Recombinant Protein (Cat# AAA434292)

Full Name

Recombinant Spike RBD Protein of SARS-CoV-2 Brazil Variant

Applications

EIA

Purity

> 95% (by SDS-PAGE)

Pricing

$385/0.05 mg | $1,580/5x0.05 mg

Viral Protein U, Blocking Peptide (Cat# AAA544651)

Full Name

Viral Protein U Antibody Antigenic Blocking Peptide

Applications

Immunocompetition, Immunodepletion

Pricing

$280/0.25 mg | $1,110/5x0.25 mg

COVID 19 Spike RBD Coronavirus, Recombinant Protein (Cat# AAA430579)

Full Name

Spike RBD (SARS-CoV-2) protein, 6xhis-tag

Applications

EIA

Purity

>=95% (SDS-PAGE)

Pricing

$410/0.05 mg | $1,685/5x0.05 mg

< >

<< Previous Next >>

Testing Data (Surface Staining of buffy coat differentiated monocytes by Mouse anti Human CD169:RPE )

Testing Data (PE conjugated Mouse anti CD169 antibody, clone 7-239 used for the evaluation of CD169 expression on myeloid cell populations by flow cytometry. Mouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeliod cells.Image caption:Siglec-1 mediates HIV-1 capture by IFN?-treated myeloid cells. A. Representative profiles of Siglec-1 staining in distinct myeloid cells cultured with or without 1000 U/ml of IFN? and assessed by FACS. Staining of matched-isotype control is also shown. The mean fold increase in fluorescence after IFN&apha; treatment of cells derived from three donors is shown in red numbers. B. Mean number of Siglec-1 antibody binding sites per cell displayed by different myeloid cells exposed to 1000 U/ml of IFN? for 48 h and assessed by quantitative FACS analysis. Data show mean values and SEM from four experiments including cells from 12 donors. C. Comparative binding of HIV-1NL4–3 to different myeloid cells ly exposed to 1000 U/ml of IFN? for 48 h. Cells were cultured with HIV-1NL4–3 for 4 h at 4°C, washed and lysed to measure p24Gag by ELISA. Data show mean values and SEM from two experiments including cells from six donors. D. Relative binding of HIV-1NL4–3 by different IFN?-treated myeloid cells that had been pre-incubated with 10 ug/ml of the indicated mAbs before HIV-1 exposure for 4 h at 4°C as described in C. To compare the effect of the mAbs in different myeloid cells, values were normalized to the level of HIV-1 binding by mock-treated cells (set to 100%). Data show mean values and SEM from two experiments including cells from six donors. Statistical differences were assessed with a paired t test in B and C, and with a one sample t-test in D.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

Testing Data (PE conjugatedMouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeloid cells.Image caption:Siglec-1 mediates HIV-1 uptake into a storage compartment and enhances HIV-1 trans-infection specially in IFN?-treated monocytes and DCs. A. Uptake of HIV-1NL4–3 by different myeloid cells exposed to IFN?. Cells were cultured with HIV-1 to measure p24Gag by ELISA. Mean values and SEM from four experiments include cells from 12 donors. B. Fold change in HIV-1NL4–3 uptake of cells treated with bafilomycin A1 compared to untreated cells. Mean values and SEM include cells from three donors. C. Relative uptake of HIV-1NL4–3 by IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 uptake by mock-treated cells (set at 100%). Mean values and SEM from two experiments include cells from six donors. D. Confocal microscopy analysis of different IFN?-treated myeloid cells pulsed with HIV-1Cherry and stained for Siglec-1 (Alexa 488), HLA-DR (Alexa 647) and DAPI. (Top) Representative viral pattern for each kind of myeloid cell analyzed, showing maximum fluorescence intensity of four channels. (Bottom) Percentage of myeloid cells with distinct viral patterns: random distribution, polarized accumulation, and sac-like compartment formation, as illustrated in the left drawing. Mean values of 50 cells from two different donors are shown. E. HIV-1 transmission from IFN?-treated myeloid cells to a luciferase reporter CD4+ cell line. HIV-1 infection was determined by induced luciferase activity in relative light units (RLUs). Mean values and SEM from four experiments include cells from 12 donors. F. Relative HIV-1 transmission from IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 trans-infected by mock-treated cells. Mean values and SEM from two experiments include cells from six donors. Statistical differences were assessed with a paired t test in A and E, and with a one sample t-test in B, C and F.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

CD169, Monoclonal Antibody (Cat# AAA225766)

Full Name

Mouse Anti Human CD169: APC

Gene Names

SIGLEC1; SN; CD169; SIGLEC-1

Reactivity

Human

Applications

FC/FACS

Purity

>95% by SDS PAGE
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.

Pricing

$555/100 Tests | $2,340/5x100 Tests

< >

<< Previous Next >>

Testing Data (Surface Staining of buffy coat differentiated monocytes by Mouse anti Human CD169:RPE )

Testing Data (PE conjugated Mouse anti CD169 antibody, clone 7-239 used for the evaluation of CD169 expression on myeloid cell populations by flow cytometry. Mouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeliod cells.Image caption:Siglec-1 mediates HIV-1 capture by IFN?-treated myeloid cells. A. Representative profiles of Siglec-1 staining in distinct myeloid cells cultured with or without 1000 U/ml of IFN? and assessed by FACS. Staining of matched-isotype control is also shown. The mean fold increase in fluorescence after IFN&apha; treatment of cells derived from three donors is shown in red numbers. B. Mean number of Siglec-1 antibody binding sites per cell displayed by different myeloid cells exposed to 1000 U/ml of IFN? for 48 h and assessed by quantitative FACS analysis. Data show mean values and SEM from four experiments including cells from 12 donors. C. Comparative binding of HIV-1NL4–3 to different myeloid cells ly exposed to 1000 U/ml of IFN? for 48 h. Cells were cultured with HIV-1NL4–3 for 4 h at 4°C, washed and lysed to measure p24Gag by ELISA. Data show mean values and SEM from two experiments including cells from six donors. D. Relative binding of HIV-1NL4–3 by different IFN?-treated myeloid cells that had been pre-incubated with 10 ug/ml of the indicated mAbs before HIV-1 exposure for 4 h at 4°C as described in C. To compare the effect of the mAbs in different myeloid cells, values were normalized to the level of HIV-1 binding by mock-treated cells (set to 100%). Data show mean values and SEM from two experiments including cells from six donors. Statistical differences were assessed with a paired t test in B and C, and with a one sample t-test in D.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

Testing Data (PE conjugatedMouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeloid cells.Image caption:Siglec-1 mediates HIV-1 uptake into a storage compartment and enhances HIV-1 trans-infection specially in IFN?-treated monocytes and DCs. A. Uptake of HIV-1NL4–3 by different myeloid cells exposed to IFN?. Cells were cultured with HIV-1 to measure p24Gag by ELISA. Mean values and SEM from four experiments include cells from 12 donors. B. Fold change in HIV-1NL4–3 uptake of cells treated with bafilomycin A1 compared to untreated cells. Mean values and SEM include cells from three donors. C. Relative uptake of HIV-1NL4–3 by IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 uptake by mock-treated cells (set at 100%). Mean values and SEM from two experiments include cells from six donors. D. Confocal microscopy analysis of different IFN?-treated myeloid cells pulsed with HIV-1Cherry and stained for Siglec-1 (Alexa 488), HLA-DR (Alexa 647) and DAPI. (Top) Representative viral pattern for each kind of myeloid cell analyzed, showing maximum fluorescence intensity of four channels. (Bottom) Percentage of myeloid cells with distinct viral patterns: random distribution, polarized accumulation, and sac-like compartment formation, as illustrated in the left drawing. Mean values of 50 cells from two different donors are shown. E. HIV-1 transmission from IFN?-treated myeloid cells to a luciferase reporter CD4+ cell line. HIV-1 infection was determined by induced luciferase activity in relative light units (RLUs). Mean values and SEM from four experiments include cells from 12 donors. F. Relative HIV-1 transmission from IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 trans-infected by mock-treated cells. Mean values and SEM from two experiments include cells from six donors. Statistical differences were assessed with a paired t test in A and E, and with a one sample t-test in B, C and F.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

CD169, Monoclonal Antibody (Cat# AAA225768)

Full Name

Mouse Anti Human CD169: RPE

Gene Names

SIGLEC1; SN; CD169; SIGLEC-1

Reactivity

Human

Applications

FC/FACS

Purity

>95% by SDS PAGE
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.

Pricing

$555/100 Tests | $2,340/5x100 Tests

< >

BMI1, Polyclonal Antibody (Cat# AAA2555034)

Full Name

BMI1 Polyclonal Antibody

Gene Names

COMMD3-BMI1; BMI1; PCGF4; RNF51

Reactivity

Human, Mouse

Applications

WB, IF

Purity

Affinity Purification

Pricing

$405/0.2 mL | $255/0.12 mL | $180/0.06 mL | $1,825/5x0.2 mL

VPU, Polyclonal Antibody (Cat# AAA7149228)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate BH10)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate BH10)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

< >

THRB, Polyclonal Antibody (Cat# AAA2565423)

Full Name

THRB Polyclonal Antibody

Gene Names

THRB; GRTH; PRTH; THR1; ERBA2; NR1A2; THRB1; THRB2; C-ERBA-2; C-ERBA-BETA

Reactivity

Human, Mouse, Rat

Applications

WB, IF

Purity

Affinity purification

Pricing

$405/0.2 mL | $255/0.12 mL | $180/0.06 mL | $1,825/5x0.2 mL

VPU, Polyclonal Antibody (Cat# AAA9001682)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (strain 89.6)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (strain 89.6)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7162177)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate BH8)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate BH8)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

< >

<< Previous Next >>

Western Blot (WB) (Western blot (WB) analysis of NFKB-p65 polyclonal antibody at 1:500 dilution Lane1:A549 whole cell lysate(40ug) Lane2:U-87MG whole cell lysate(40ug) Lane3:MCF-7 whole cell lysate(40ug))

NFKB-p65, Polyclonal Antibody (Cat# AAA3004404)

Full Name

NFKB-p65 polyclonal antibody

Gene Names

RELA; p65; NFKB3

Reactivity

Human, Mouse, Rat

Applications

WB, IP, IF

Purity

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

Pricing

$275/0.05 mL | $365/0.1 mL | $1,375/5x0.1 mL

< >

<< Previous Next >>

Testing Data (Surface Staining of buffy coat differentiated monocytes by Mouse anti Human CD169:RPE )

Testing Data (PE conjugated Mouse anti CD169 antibody, clone 7-239 used for the evaluation of CD169 expression on myeloid cell populations by flow cytometry. Mouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeliod cells.Image caption:Siglec-1 mediates HIV-1 capture by IFN?-treated myeloid cells. A. Representative profiles of Siglec-1 staining in distinct myeloid cells cultured with or without 1000 U/ml of IFN? and assessed by FACS. Staining of matched-isotype control is also shown. The mean fold increase in fluorescence after IFN&apha; treatment of cells derived from three donors is shown in red numbers. B. Mean number of Siglec-1 antibody binding sites per cell displayed by different myeloid cells exposed to 1000 U/ml of IFN? for 48 h and assessed by quantitative FACS analysis. Data show mean values and SEM from four experiments including cells from 12 donors. C. Comparative binding of HIV-1NL4–3 to different myeloid cells ly exposed to 1000 U/ml of IFN? for 48 h. Cells were cultured with HIV-1NL4–3 for 4 h at 4°C, washed and lysed to measure p24Gag by ELISA. Data show mean values and SEM from two experiments including cells from six donors. D. Relative binding of HIV-1NL4–3 by different IFN?-treated myeloid cells that had been pre-incubated with 10 ug/ml of the indicated mAbs before HIV-1 exposure for 4 h at 4°C as described in C. To compare the effect of the mAbs in different myeloid cells, values were normalized to the level of HIV-1 binding by mock-treated cells (set to 100%). Data show mean values and SEM from two experiments including cells from six donors. Statistical differences were assessed with a paired t test in B and C, and with a one sample t-test in D.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

Testing Data (PE conjugatedMouse anti Human CD169 antibody, clone 7-239 used to block CD169 function on myeloid cells.Image caption:Siglec-1 mediates HIV-1 uptake into a storage compartment and enhances HIV-1 trans-infection specially in IFN?-treated monocytes and DCs. A. Uptake of HIV-1NL4–3 by different myeloid cells exposed to IFN?. Cells were cultured with HIV-1 to measure p24Gag by ELISA. Mean values and SEM from four experiments include cells from 12 donors. B. Fold change in HIV-1NL4–3 uptake of cells treated with bafilomycin A1 compared to untreated cells. Mean values and SEM include cells from three donors. C. Relative uptake of HIV-1NL4–3 by IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 uptake by mock-treated cells (set at 100%). Mean values and SEM from two experiments include cells from six donors. D. Confocal microscopy analysis of different IFN?-treated myeloid cells pulsed with HIV-1Cherry and stained for Siglec-1 (Alexa 488), HLA-DR (Alexa 647) and DAPI. (Top) Representative viral pattern for each kind of myeloid cell analyzed, showing maximum fluorescence intensity of four channels. (Bottom) Percentage of myeloid cells with distinct viral patterns: random distribution, polarized accumulation, and sac-like compartment formation, as illustrated in the left drawing. Mean values of 50 cells from two different donors are shown. E. HIV-1 transmission from IFN?-treated myeloid cells to a luciferase reporter CD4+ cell line. HIV-1 infection was determined by induced luciferase activity in relative light units (RLUs). Mean values and SEM from four experiments include cells from 12 donors. F. Relative HIV-1 transmission from IFN?-treated myeloid cells pre-incubated with the indicated mAbs. Values are normalized to the level of HIV-1 trans-infected by mock-treated cells. Mean values and SEM from two experiments include cells from six donors. Statistical differences were assessed with a paired t test in A and E, and with a one sample t-test in B, C and F.From: Pino M, Erkizia I, Benet S, Erikson E, Fernández-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J, Izquierdo-Useros N.HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.Retrovirology. 2015 May 7;12:37.This image is from an open access article distributed under the terms of the Creative Commons Attribution License.)

CD169, Monoclonal Antibody (Cat# AAA225767)

Full Name

Mouse Anti Human CD169

Gene Names

SIGLEC1; SN; CD169; SIGLEC-1

Reactivity

Human

Applications

IHC, FC/FACS, FN, IP, WB

Purity

>95% by SDS PAGE
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.

Pricing

$380/0.1 mg | $1,565/5x0.1 mg

LYN, Antibody (Cat# AAA1800923)

Full Name

Anti-LYN Purified

Gene Names

LYN; JTK8; p53Lyn; p56Lyn

Reactivity

Rat, Human, Mouse

Applications

WB, ICC

Purity

Purified by Protein-A Affinity Chromatography

Pricing

$290/0.1 mg | $1,095/5x0.1 mg

REV, Polyclonal Antibody (Cat# AAA7164518)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype U (isolate Z3)(HIV-1) REV Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype U (isolate Z3)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7162181)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate MN)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate MN)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

< >

Herpes Simplex Virus I & II, Monoclonal Antibody (Cat# AAA370434)

Full Name

Herpes Simplex Virus I & II MMab (10A3 & BSB-116)

Reactivity

Human

Pricing

FOSB, Polyclonal Antibody (Cat# AAA3015037)

Full Name

FOSB (Phospho-S27) polyclonal antibody

Gene Names

FOSB; AP-1; G0S3; GOS3; GOSB

Reactivity

Human, Mouse

Applications

WB, IHC, IF

Purity

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is >95% (by SDS-PAGE)

Pricing

$310/0.05 mL | $435/0.1 mL | $1,695/5x0.1 mL

VPU, Polyclonal Antibody (Cat# AAA7181771)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype F1 (isolate 93BR020)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype F1 (isolate 93BR020)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7181772)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype H (isolate 90CF056)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype H (isolate 90CF056)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7164547)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate SC)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate SC)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7157248)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate YU-2)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate YU-2)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7162179)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype D (isolate ELI)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype D (isolate ELI)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7162429)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype D (isolate Z84)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype D (isolate Z84)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7152184)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate RF/HAT3)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate RF/HAT3)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

< >

<< Previous Next >>

Immunofluorescence (IF) (Immunofluorescence analysis of C6 cells using Pan-AKT Polyclonal Antibody at dilution of 1:100. Blue: DAPI for nuclear staining.)

Pan-AKT, Polyclonal Antibody (Cat# AAA2566131)

Full Name

Pan-AKT Polyclonal Antibody

Gene Names

AKT1; AKT; PKB; RAC; CWS6; PRKBA; PKB-ALPHA; RAC-ALPHA

Reactivity

Human, Mouse, Rat

Applications

IF

Purity

Affinity purification

Pricing

$405/0.2 mL | $255/0.12 mL | $180/0.06 mL | $1,825/5x0.2 mL

VPU, Polyclonal Antibody (Cat# AAA7153103)

Full Name

Rabbit anti-Simian immunodeficiency virus (isolate CPZ GAB1)(SIV-cpz)(Chimpanzee immunodeficiency virus) VPU Polyclonal Antibody

Reactivity

Simian immunodeficiency virus (isolate CPZ GAB1)(SIV-cpz)(Chimpanzee immunodeficiency virus)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7197374)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype C (isolate ETH2220)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype C (isolate ETH2220)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7197037)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate LW123)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate LW123)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7151707)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (isolate BRVA)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype B (isolate BRVA)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7162178)

Full Name

Rabbit anti-Human immunodeficiency virus type 1 group M subtype A (isolate MAL)(HIV-1) VPU Polyclonal Antibody

Reactivity

Human immunodeficiency virus type 1 group M subtype A (isolate MAL)(HIV-1)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

VPU, Polyclonal Antibody (Cat# AAA7190526)

Full Name

Rabbit anti-Simian immunodeficiency virus (isolate EK505)(SIV-cpz)(Chimpanzee immunodeficiency virus) VPU Polyclonal Antibody

Reactivity

Simian immunodeficiency virus (isolate EK505)(SIV-cpz)(Chimpanzee immunodeficiency virus)

Applications

EIA, Western Blot, ensure identification of antigen

Purity

Protein A/G

Loading...

Filters

Clonality

Type

Reactivity

Gene Name

Isotype

Host

Application

Clone

78 results for " Viral Protein U Antibody" - showing 1-50

V5-TAG, Monoclonal Antibody (Cat# AAA212109)

V5-TAG, Monoclonal Antibody (Cat# AAA210328)

V5-TAG, Monoclonal Antibody (Cat# AAA214958)

V5-TAG, Monoclonal Antibody (Cat# AAA210664)

V5-TAG, Monoclonal Antibody (Cat# AAA216888)

gp120 (HIV-1/Clade B), Recombinant Protein (Cat# AAA434004)

E (DIII) (WNV), Recombinant Protein (Cat# AAA434001)

Spike(Beijing02)(SARS-CoV), Recombinant Protein (Cat# AAA434077)

HIV-1 gp140, Recombinant Protein (Cat# AAA434072)

gp120 (MN) (HIV-1/Clade B), Recombinant Protein (Cat# AAA434051)

Viral Protein U, Polyclonal Antibody (Cat# AAA540387)

Membrane Glycoprotein G1 of Phlebovirus, Recombinant Protein (Cat# AAA434236)

Measles Virus, Monoclonal Antibody (Cat# AAA319675)

BMI1, Polyclonal Antibody (Cat# AAA625868)

Viral Protein U, Polyclonal Antibody (Cat# AAA5400233)

Viral Protein U, Polyclonal Antibody (Cat# AAA5400232)

XBP1, Polyclonal Antibody (Cat# AAA1491360)

HA (B/Colorado/06/2017), Recombinant Protein (Cat# AAA430291)

Viral Protein U, Positive Control (Cat# AAA543376)

COVID 19 Spike RBD Brazil Variant Coronavirus, Recombinant Protein (Cat# AAA434292)

Viral Protein U, Blocking Peptide (Cat# AAA544651)

COVID 19 Spike RBD Coronavirus, Recombinant Protein (Cat# AAA430579)

CD169, Monoclonal Antibody (Cat# AAA225766)

CD169, Monoclonal Antibody (Cat# AAA225768)

BMI1, Polyclonal Antibody (Cat# AAA2555034)

VPU, Polyclonal Antibody (Cat# AAA7149228)

THRB, Polyclonal Antibody (Cat# AAA2565423)

VPU, Polyclonal Antibody (Cat# AAA9001682)

VPU, Polyclonal Antibody (Cat# AAA7162177)

NFKB-p65, Polyclonal Antibody (Cat# AAA3004404)

CD169, Monoclonal Antibody (Cat# AAA225767)

LYN, Antibody (Cat# AAA1800923)

REV, Polyclonal Antibody (Cat# AAA7164518)

VPU, Polyclonal Antibody (Cat# AAA7162181)

Herpes Simplex Virus I & II, Monoclonal Antibody (Cat# AAA370434)

FOSB, Polyclonal Antibody (Cat# AAA3015037)

VPU, Polyclonal Antibody (Cat# AAA7181771)

VPU, Polyclonal Antibody (Cat# AAA7181772)

VPU, Polyclonal Antibody (Cat# AAA7164547)

VPU, Polyclonal Antibody (Cat# AAA7157248)

VPU, Polyclonal Antibody (Cat# AAA7162179)

VPU, Polyclonal Antibody (Cat# AAA7162429)

VPU, Polyclonal Antibody (Cat# AAA7152184)

Pan-AKT, Polyclonal Antibody (Cat# AAA2566131)

VPU, Polyclonal Antibody (Cat# AAA7153103)

VPU, Polyclonal Antibody (Cat# AAA7197374)

VPU, Polyclonal Antibody (Cat# AAA7197037)

VPU, Polyclonal Antibody (Cat# AAA7151707)

VPU, Polyclonal Antibody (Cat# AAA7162178)

VPU, Polyclonal Antibody (Cat# AAA7190526)

Contact us by

Request more Information

Request a Manual

Request a Quote